Michael Meisenheimer

Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer

Anna Yordanova, Paula Linden, Stefan Hauser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 86 citations

Medicine, Oncology, Urology +12

Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation

Dominik Kraus, Jan Reckenbeil, Nadine Veit et al. · Cellular Oncology · 2018 · 83 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

[44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma

Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes et al. · Clinical Nuclear Medicine · 2018 · 38 citations

Medicine, Nuclear Medicine, Oncology +17

Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases

Ambreen Khawar, Elisabeth Eppard, Frank Roesch et al. · Annals of Nuclear Medicine · 2019 · 38 citations

Medicine, Medicinal Chemistry, Nuclear Medicine +10

Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma

Ambreen Khawar, Elisabeth Eppard, Jean Phlippe Sinnes et al. · Clinical Nuclear Medicine · 2018 · 28 citations

Medicine, Oncology, Pharmacokinetics +17